13F filer · CIK 19617 ↗

Jpmorgan Chase & Co

You are looking at Q4 2017. See the latest, Q2 2026 →

Reported value

$474.64B

+4.7% on the quarter before

Positions

5,474

868 new · 404 sold out

Top 10

17.8%

of the value

Est. gain

+$23.29B

on stocks held all quarter

Est. return

+6.1%

on those stocks since Q3 2017

Filed

Feb 13, 2018

On SEC EDGAR ↗

Positions as of Dec 31, 2017, from Jpmorgan Chase & Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.

SPDR S&P 500 ETF Tr6.3%
Ishares Tr2.1%
Apple1.8%Microsoft1.7%
Bank Amer Corp1.1%
Unitedhealth Group Inc1.0%
Alphabet1.0%Amazon1.0%
Pfizer Inc0.9%
Meta0.8%
Ishares Tr0.8%
Home Depot Inc0.8%
Wells Fargo Co New0.8%
Ishares TrPUT0.8%
Citigroup Inc0.8%
Alphabet0.7%
Johnson & Johnson0.7%
Texas Instruments0.6%Visa Inc.0.6%
Occidental Pete Corp Del0.6%
Ishares Tr0.6%
Alibaba0.5%Morgan Stanley0.5%
Pepsico Inc0.5%

Largest buys

Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Johnson & Johnson~$763.0MAdded · 0.5% → 0.7%+5,460,967 shares
  2. Ishares Tr~$738.4MAdded · 0.0% → 0.2%+6,073,984 shares
  3. Ishares TrPUT~$579.8MAdded · 0.6% → 0.8%+4,065,300 underlying
  4. Zimmer Biomet Hldgs Inc~$562.0MAdded · 0.1% → 0.2%+4,657,372 shares
  5. Amazon~$466.9MAdded · 0.8% → 1.0%+399,223 shares
  6. Nike Inc~$454.5MAdded · 0.1% → 0.2%+7,265,414 shares
  7. Ishares Tr~$444.3MAdded · 0.7% → 0.8%+6,722,677 shares
  8. Ribbon Communications Inc~$391.0MNew · 0.0% → 0.1%+50,579,553 shares
  9. Microsoft~$390.7MAdded · 1.4% → 1.7%+4,566,871 shares
  10. General Mtrs CoCALL~$375.3MAdded · 0.0% → 0.1%+9,156,900 underlying

Largest sells

Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. SPDR S&P 500 ETF Tr~$4.11BCut · 7.0% → 6.3%−15,405,677 shares
  2. SPDR S&P 500 ETF TrPUT~$1.63BCut · 0.8% → 0.4%−6,097,011 underlying
  3. Powershares Qqq TrustPUT~$1.54BCut · 0.4% → 0.1%−9,880,907 underlying
  4. Vanguard Index Fds~$1.13BCut · 0.6% → 0.3%−4,625,817 shares
  5. Tjx Cos Inc New~$718.9MCut · 0.2% → 0.1%−9,402,284 shares
  6. Altaba Inc~$701.2MCut · 0.2% → 0.1%−10,039,278 shares
  7. Ishares Tr~$653.9MCut · 0.2% → 0.0%−5,154,603 shares
  8. Ishares TrCALL~$625.6MCut · 0.2% → 0.1%−4,492,400 underlying
  9. Broadcom Ltd~$575.3MCut · 0.6% → 0.5%−2,239,246 shares
  10. Adobe~$480.9MCut · 0.4% → 0.3%−2,744,379 shares

Holdings

As of Dec 31, 2017. Changes are in shares against Sep 30, 2017, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
SPDR S&P 500 ETF TrFUND · shares −12% · price +6.6%6.3%$29.90B+$1.85B
Ishares TrFUND · shares −0.3% · price +3.3%2.1%$10.19B+$323.3M
AppleCOMMON · shares −2.2% · price +10.4%1.8%$8.74B+$823.4M
MicrosoftCOMMON · shares +5.2% · price +15.8%1.7%$7.97B+$1.03B
Bank Amer CorpCOMMON · shares −1.2% · price +16.0%1.1%$5.31B+$732.6M
Unitedhealth Group IncCOMMON · shares −4.0% · price +12.4%1.0%$4.85B+$536.3M
AlphabetCOMMON · shares −0.06% · price +10.2%0.99%$4.72B+$437.3M
AmazonCOMMON · shares +11% · price +22.3%0.99%$4.70B+$772.0M
Pfizer IncCOMMON · shares +1.3% · price +1.7%0.88%$4.19B+$70.7M
MetaCOMMON · shares −1.2% · price +4.6%0.83%$3.95B+$173.1M
Ishares TrFUND · shares +13% · price +3.6%0.83%$3.92B+$119.3M
Home Depot IncCOMMON · shares −2.0% · price +16.7%0.81%$3.85B+$551.5M
Wells Fargo Co NewCOMMON · shares −4.5% · price +11.8%0.79%$3.75B+$397.3M
Ishares TrPUTOPTION · shares +18%0.79%$3.74B—
Citigroup IncCOMMON · shares −0.4% · price +2.4%0.77%$3.65B+$86.3M
AlphabetCOMMON · shares +11% · price +9.2%0.71%$3.36B+$255.4M
Johnson & JohnsonCOMMON · shares +30% · price +7.9%0.70%$3.31B+$186.6M
Texas InstrumentsCOMMON · shares −3.1% · price +16.5%0.63%$2.98B+$422.6M
Visa Inc.COMMON · shares +4.2% · price +9.0%0.61%$2.87B+$228.4M
Occidental Pete Corp DelCOMMON · shares +0.8% · price +13.4%0.59%$2.78B+$325.1M
Ishares TrFUND · shares −8.0% · price +6.7%0.58%$2.73B+$171.3M
AlibabaADR · shares +0.8% · price +1.3%0.55%$2.61B+$32.9M
Morgan StanleyCOMMON · shares +0.08% · price +9.0%0.54%$2.57B+$211.7M
Pepsico IncCOMMON · shares +4.9% · price +7.4%0.52%$2.48B+$163.0M
Broadcom LtdCOMMON · shares −19% · price +5.7%0.51%$2.44B+$132.6M
Total · 5,474 positions100%$474.64B+$23.29B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2017 to Q4 2017: 3,841 stocks held throughout, up $23.29B (+6.1%).

  1. SPDR S&P 500 ETF Tr+$1.85B+7%
  2. Microsoft+$1.03B+16%
  3. Apple+$823.4M+10%
  4. Amazon+$772.0M+22%
  5. Bank Amer Corp+$732.6M+16%
  6. Pq Group Hldgs Inc−$221.5M−87%
  7. General Electric Co−$242.2M−28%
  8. Merck & Co Inc−$263.9M−12%
  9. Allergan Plc−$287.4M−20%
  10. Celgene Corp−$326.4M−27%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 16 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$4.00T$2.00T$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$1.81T+16%SEC ↗
Q1 2026$1.56T−2%SEC ↗
Q4 2025$1.59T−52%SEC ↗
Q3 2025$3.34T+118%SEC ↗
Q2 2025$1.53T+12%SEC ↗
Q1 2025$1.37T+2%SEC ↗
Q4 2024$1.34T−49%SEC ↗
Q3 2024$2.63T+8%SEC ↗
Q2 2024$2.44T+3%SEC ↗
Q1 2024$2.37T+14%SEC ↗
Q4 2023$2.08T+130%SEC ↗
Q3 2023$906.36B−2%SEC ↗
Q2 2023$920.27B+12%SEC ↗
Q1 2023$820.88B+8%SEC ↗
Q4 2022$758.55B+9%SEC ↗
Q3 2022$696.38B−3%SEC ↗
Q2 2022$717.86B−14%SEC ↗
Q1 2022$830.28B−4%SEC ↗
Q4 2021$865.90B+7%SEC ↗
Q3 2021$808.68B−4%SEC ↗
Q2 2021$838.21B+12%SEC ↗
Q1 2021$749.21B+10%SEC ↗
Q4 2020$680.63B+14%SEC ↗
Q3 2020$595.09B+15%SEC ↗
Q2 2020$518.17B+22%SEC ↗
Q1 2020$425.90B−21%SEC ↗
Q4 2019$536.28B+7%SEC ↗
Q3 2019$502.15B−2%SEC ↗
Q2 2019$511.43B+4%SEC ↗
Q1 2019$489.55B+13%SEC ↗
Q4 2018$432.49B−17%SEC ↗
Q3 2018$522.20B+7%SEC ↗
Q2 2018$486.35B+4%SEC ↗
Q1 2018$466.55B−2%SEC ↗
Q4 2017$474.64B+5%SEC ↗
Q3 2017$453.26B+4%SEC ↗
Q2 2017$437.53B−0%SEC ↗
Q1 2017$437.58B+5%SEC ↗
Q4 2016$416.17B+2%SEC ↗
Q3 2016$406.33B+1%SEC ↗
Q2 2016$401.04B+3%SEC ↗
Q1 2016$390.67BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.